News

Hong Kong Housing Society : Their Commitment to Advocate Ageing-in-Place

The ageing of the population is an undeniable global phenomenon. This has, no doubt, been bringing along quite some challenges to the economy, social welfare, labour market, and healthcare systems, yet it is a futuristic experience travelling into the unknown as the global population is ageing and living longer than ever in history. The expertise, […]

Hong Kong Housing Society : Their Commitment to Advocate Ageing-in-Place Read More »

DeVi-Stairlifts : winner of the SilverEco & Ageing Well International Awards 2022 representing the Netherlands

Developing responsible and reusable stairlifts is the solution that offers DeVi-Stairlifts. This solution was naturally selected to be the winner of the International Awards representing the Netherlands at the SilverNight, on Monday 12th of September.

DeVi-Stairlifts : winner of the SilverEco & Ageing Well International Awards 2022 representing the Netherlands Read More »

Macrosad : winner of the SilverEco & Ageing Well International Awards 2022 representing Spain

Organizing encounters between toddlers and the older population is the solution that offers CINTER. This solution was naturally selected to be the winner of the International Awards representing Spain at the SilverNight, on Monday 12th of September.

Macrosad : winner of the SilverEco & Ageing Well International Awards 2022 representing Spain Read More »

My-own-voice : Acapela Group’s innovation that reproduces your voice in digital at CES Las Vegas 2023 !

Because many people suffer from voice disorders or loss of voice due to serious illness or surgery (ALS, autism, aphasia, cerebral palsy, dysarthria, laryngectomy, etc.), Acapela Group, the European leader in voice solutions based in Toulouse, has designed “My-own-voice” : an innovative web service available in more than 20 languages that allows anyone to easily

My-own-voice : Acapela Group’s innovation that reproduces your voice in digital at CES Las Vegas 2023 ! Read More »

Light4life : a pivotal clinical study by REGEnLIFE to evaluate the therapeutic efficacy of its photomedical technology in Alzheimer’s disease

During the 15th edition of the CTAD (Clinical Trials on Alzheimer’s Disease) taking place from November 29 to December 2 of 2022 in San Francisco, USA, REGEnLIFE, a French company specialized in the research and development of innovative technologies in photo-medicine for the prevention and treatment of neurodegenerative diseases, presented the concept of its next

Light4life : a pivotal clinical study by REGEnLIFE to evaluate the therapeutic efficacy of its photomedical technology in Alzheimer’s disease Read More »

Scroll to Top